Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Axogen, Inc. - Common Stock (NQ:AXGN)

10.97 +0.17 (+1.57%)
Streaming Delayed Price Updated: 3:05 PM EDT, Jun 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Axogen, Inc. - Common Stock

< Previous 1 2 3 4 Next >
Axogen, Inc. Begins Processing Avance® Nerve Graft at New State-of-the-Art Facility in Dayton, Ohio
From Axogen, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Dow Drops 343 Points Amid Bank Sector Gloom
Stocks are extending their morning losses, with the banking sector weighing on the market after Moody cut its credit rating on several U.S. banks. 
Via Talk Markets
Axogen, Inc. Reports 2023 Second Quarter Financial Results
From Axogen, Inc.
Via GlobeNewswire
Axogen Earnings Perspective: Return On Capital Employed
Via Benzinga
A Preview Of Axogen's Earnings
Via Benzinga
Read JMP Securities' Take On Axogen's Interim Update
Via Benzinga
Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 185.6% to $1.6593 after the company announced contract with NASA to demonstrate feasibility of power beaming in space using the company’s blue laser... 
Via Benzinga
Axogen to Participate at Canaccord Genuity’s 43rd Annual Growth Conference
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. to report second quarter 2023 financial results and host conference call on August 7, 2023
From Axogen, Inc.
Via GlobeNewswire
Axogen to Participate at Jefferies Healthcare Conference
From Axogen, Inc.
Via GlobeNewswire
Axogen to Participate at JMP Securities Life Sciences Conference
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. Reports 2023 First Quarter Financial Results
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. to report first quarter 2023 financial results and host conference call on May 9, 2023
From Axogen, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Axogen, Inc Reports 2022 Fourth Quarter and Full-Year Financial Results
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. Appoints Marc Began as Executive Vice President and General Counsel
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. to report fourth quarter 2022 financial results and host conference call on March 14, 2023
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. Appoints Jens Schroeder Kemp as Chief Marketing Officer
From Axogen, Inc.
Via GlobeNewswire
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022
From Axogen, Inc.
Via GlobeNewswire
Axogen Announces Independent Publication of Comparative Nerve Gap Repair Meta-Analysis of 35 peer-reviewed studies of Allograft, Autograft, and Conduits
Study concluded allograft and autograft repairs delivered significantly better rates of meaningful sensory recovery in short gaps as compared to conduit repairs in a systematic meta-analysis including... 
From Axogen, Inc.
Via GlobeNewswire
Axogen to Participate at J.P. Morgan 41st Annual Healthcare Conference
From Axogen, Inc.
Via GlobeNewswire
Axogen Patient to Ride the 2023 Donate Life Rose Parade® Float Supporting awareness of organ and tissue donation
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc Reports 2022 Third Quarter Financial Results
From Axogen, Inc.
Via GlobeNewswire
Axogen to Participate at Upcoming Investor Conferences
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. announces the appointment of Adrian Tyndall, M.D. MPH, FACEP to its Board of Directors and the retirement of founding Director Mark Gold, M.D.
Dr. Tyndall is currently the Executive Vice President for Health Affairs and Dean of Morehouse School of Medicine. 
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. to report third quarter 2022 financial results and host conference call on November 8, 2022
From Axogen, Inc.
Via GlobeNewswire
Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday
Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in... 
Via Benzinga
Axogen: Q2 Earnings Insights
Axogen (NASDAQ:AXGN) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Axogen beat estimated earnings by... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2022
Upgrades 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.